Surfactant Protein A Recognizes Outer Membrane Protein OprH on Pseudomonas aeruginosa Isolates from Individuals with Chronic Infection

Journal of Infectious Diseases

Volumn 214, Issue 9, 2016, Pages 1449-1455

  Qadi, Mohammad ^a   Lopez Causapé, Carla ^b,c   Izquierdo Rabassa, Sofia ^a   Mateu Borrás, Margalida ^a   Goldberg, Joanna B ^d,e   Oliver, Antonio ^b,c   Albertí, Sebastián ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Universitario de Albacete   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d Department of Pediatrics ^*  (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cystic fibrosis; outer membrane protein OprH; Pseudomonas aeruginosa; surfactant protein A

Indexed keywords

OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN OPRH; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG; OPRH PROTEIN, PSEUDOMONAS AERUGINOSA;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; INFECTION; MACROPHAGE; MOLECULAR CLONING; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; LUNG; METABOLISM; MICROBIOLOGY; PSEUDOMONAS INFECTION;

BACTERIAL OUTER MEMBRANE PROTEINS; CYSTIC FIBROSIS; HUMANS; LUNG; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

EID: 84994735139     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw387     Document Type: Article

References (24)

1. Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60:539-74
2. Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 1994; 62:596-605
3. Speert D, Campbell M, Puterman ML, et al. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J Infect Dis 1994; 169:134-42
4. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000; 288:1251-3
5. Mariencheck WI, Savov J, Dong Q, Tino MJ, Wright JR. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol 1999; 277:L777-86
6. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998; 19:700-8
7. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111:1589-602
8. Van Iwaarden JF, Pikaar JC, Storm J, et al. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J 1994; 303:407-11
9. Hickling TP, SIm RB, Malhotra R. Induction of TNF-alpha release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A. FEBS lett 1998; 437:65-9
10. López-Causapé C, Rojo-Molinero E, Mulet X, et al. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. PLoS One 2013; 8:e71001
11. Edrington TC, Kintz E, Goldberg JB, Tamm LK. Structural basis for the interaction of lipopolysaccharide with outer membrane protein H (OprH) from Pseudomonas aeruginosa. J Biol Chem 2011; 286:39211-23
12. Strong P, Kishore U, Morgan C, Lopez Bernal A, Singh M, Reid KB. A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J Immunol Methods 1998; 220:139-49
13. García-Sureda L, Doménech-Sánchez A, Barbier M, Juan C, Gascó J, Albertí S. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. Antimicrob Agents Chem 2010; 55:4742-7
14. Barbier M, Owings JP, Martínez-Ramos I, et al. Lysine trimethylation of EF-Tu mimics platelet-activating factor to initiate Pseudomonas aeruginosa pneumonia. MBio 2013; 4:e00207-13
15. Khubchandani KR, Oberley RE, Snyder JM. Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells. Am J Respir Cell Mol Biol 2001; 25: 699-706
16. Kovach ME, Phillips RW, Elzer PH, Roop RM, Paterson KM. pBBR1MCS: a broad-host range cloning vector. BioTechniques 1994; 16:800-2
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989
18. Tan RM, Kuang Z, Hao Y, Lau GW. Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A. J Innate Immun 2014; 6:227-39
19. McNeely TB, Coonrod JD. Aggregation and opsonization of Type A but not Type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol 1994; 11:114-22
20. Reinhart RA. Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 1988; 148:2415-20
21. Bielecki P, Komor U, Bielecka A, et al. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol. 2013; 15:570-87
22. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 2008; 4:e1000213
23. Gellatly SL, Needham B, Madera L, Trent MS, Hancock RE. The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation. Infect Immun 2012; 80:3122-31
24. Miller AK, Brannon MK, Stevens L, et al. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother 2011; 55:5761-9